KaydedilenlerDerginizi ekleyin

Dergiler / Balıkesir Sağlık Bilimleri Dergisi / 2026 / Volume: 11 Issue: 2

Multipl Sklerozlu Bireylerde Öz Bildirimli Engellilik Durumu Ölçeğinin Türkçe Versiyonunun Geçerliliği ve Güvenilirliği

Validity and Reliability of the Turkish Version of the Self-Reported Disability Status Scale in Persons with Multiple Sclerosis

Furkan Bilek(FIRAT UNIVERSITY)0000-0003-1567-7201
Caner Feyzi Demir(FIRAT UNIVERSITY, SCHOOL OF MEDICINE)0000-0002-2861-2418
Sayfa
—
Yayın Tarihi
2022-07-14
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Bulgular: SRDSS ile Genişletilmiş Engellilik Durum Ölçeği (r = -0.920, p: 0.000) ve Hasta Tarafından Belirlenmiş Hastalık Adımları (r = 0.857, p = 0.000) arasında çok güçlü bir korelasyon bulundu.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Amaç: Bu çalışmanın amacı, Özbildirimli Engellilik Durumu Ölçeği’nin (SRDSS) Türkçe versiyonunun geçerliliğini, güvenilirliğini ve kültürel uyarlamasını araştırmaktır.
📊
Temel Bulgular & Veri:Türkçe SRDSS'nin geçerlik ve test-tekrar test güvenirliği MS'li 128 kişide incelendi.
💡
Sonuç & Katkı:Bulgular: SRDSS ile Genişletilmiş Engellilik Durum Ölçeği (r = -0.920, p: 0.000) ve Hasta Tarafından Belirlenmiş Hastalık Adımları (r = 0.857, p = 0.000) arasında çok güçlü bir korelasyon bulundu.
🔬Tür:Research Article
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Multiple Sclerosis · Self-report · Validity

Özet

Amaç: Bu çalışmanın amacı, Özbildirimli Engellilik Durumu Ölçeği’nin (SRDSS) Türkçe versiyonunun geçerliliğini, güvenilirliğini ve kültürel uyarlamasını araştırmaktır. Gereç ve Yöntem: Bu çalışma prospektif, metodolojik ve kesitsel olarak tasarlandı. SRDSS'nin Türkçe çevirisi ve kültürler arası uyarlaması yapıldı. Eşzamanlı geçerliliği test etmek için SRDSS puanları Genişletilmiş Engellilik Durum Ölçeği ve Hasta Tarafından Belirlenmiş Hastalık Adımları ile karşılaştırıldı. Türkçe SRDSS'nin geçerlik ve test-tekrar test güvenirliği MS'li 128 kişide incelendi. Bulgular: SRDSS ile Genişletilmiş Engellilik Durum Ölçeği (r = -0.920, p: 0.000) ve Hasta Tarafından Belirlenmiş Hastalık Adımları (r = 0.857, p = 0.000) arasında çok güçlü bir korelasyon bulundu. SRDSS'nin ilk test ortalaması 1.29 ± 0.59, tekrar test ortalaması 1.30 ± 0.61 olarak tespit edildi. Test ile retest arasında çok yüksek bir korelasyon bulundu (p < 0,001, r = 0.967). Bland-Altman analizinde sırasıyla 0.2929 ve -0.3089 üst ve alt uyuşma sınırlarıyla SRDSS'nin tekrarlanabilir olduğunu gösterdi (bias = -0.008; p = 0.566). Cronbach's alpha katsayısı 0,983 (mükemmel güvenirlik) olarak bulundu. Değerlendiriciler arası uyum için, bireysel testteki ICC değerleri 0,967'dir (%95 CI; 0,954–0,977). Sonuç: Bu çalışma, SDRSS'nin Türkçe versiyonunun geçerli ve güvenilir bir ölçme aracı olduğunu göstermiştir. Genişletilmiş Engellilik Durum Ölçeği'nin uygulanamadığı durumlarda, alternatif bir değerlendirme yöntemi olarak SRDSS'nin Türkçe versiyonu kullanılabilir.

Abstract

Objective: The aim of this study was designed to investigate the validity, reliability, and cultural adaptation of the Turkish version of the self-reported disability status scale (SRDSS). Materials and Methods: This study was designed as prospective, methodological, and cross-sectional. Turkish translation and cross-cultural adaptation of SRDSS was conducted. SRDSS scores were compared with Expanded Disability Status Scale and Patient Determined Disease Steps to test the concurrent validity. The validity and test-retest reliability of the Turkish SRDSS were investigated in 128 persons with MS. Results: A very strong correlation was found between SRDSS and Expanded Disability Status Scale (r = -0.920, p: 0.000) and Patient Determined Disease Steps (r = 0.857, p = 0.000). The mean of the first test of SRDSS was 1.29 ± 0.59, and the mean of the retest test was 1.30 ± 0.61. A very high correlation was found between test and retest (p < 0.001, r = 0.967). Bland-Altman analysis showed that SRDSS was reproducible with upper and lower limits of agreement of 0.2929 and -0.3089, respectively (bias = -0.008; p = 0.566). Cronbach's alpha coefficient was found to be 0.983 (excellent reliability). For inter-rater agreement, the ICC values in the individual test were 0.967 (954 CI; 0.954–0.977). Conclusion: This study showed that the Turkish version of SDRSS is a valid and reliable measurement tool. In cases where Expanded Disability Status Scale cannot be applied, the Turkish version of SRDSS can be used as an alternative assessment method.

🔖

Bu Makaleye Atıf Yap

Bilek, F., Demir, C. F. (2022). Multipl Sklerozlu Bireylerde Öz Bildirimli Engellilik Durumu Ölçeğinin Türkçe Versiyonunun Geçerliliği ve Güvenilirliği. Balıkesir Sağlık Bilimleri Dergisi, Volume: 11 Issue: 2. https://doi.org/10.53424/balikesirsbd.1022783

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (29)

  1. Arafat, S. Y., Chowdhury, H. R., Qusar, M., & Hafez, M. A. (2016). Cross cultural adaptation & psychometric validation of research instruments: A methodological review. 5(3), 129-136. https://doi.org/10.5455/jbh.20160615121755
  2. Berger, V. W., & Zhou, Y. (2014). Kolmogorov–Smirnov Test: Overview. In Wiley StatsRef: Statistics Reference Online. 2014. https://doi.org/10.1002/9781118445112.stat06558
  3. Bland, J. M., & Altman, D. G. (1986). Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (London, England), 1(8476), 307–310. PMID: 2868172
  4. Bland, J. M., & Altman, D. G. (1999). Measuring agreement in method comparison studies. Statistical Methods in Medical Research, 8(2), 135–160. https://doi.org/10.1177/096228029900800204
  5. Bovis, F., Signori, A., Carmisciano, L., Maietta, I., Steinerman, J. R., Li, T., … & Sormani, M. P. (2018). Expanded disability status scale progression assessment heterogeneity in multiple sclerosis according to geographical areas. Annals of Neurology, 84(4), 621–625. https://doi.org/10.1002/ana.25323
  6. Coca-Tapia, M., Cuesta-Gómez, A., Molina-Rueda, F., & Carratalá-Tejada, M. (2021). Gait Pattern in People with Multiple Sclerosis: A Systematic Review. Diagnostics (Basel, Switzerland), 11(4), 584. https://doi.org/10.3390/diagnostics11040584
  7. Ercan, Z., Bilek, F., & Demir, C. F. (2021). The effect of aerobic exercise on Neurofilament light chain and glial Fibrillary acidic protein level in patients with relapsing remitting type multiple sclerosis. Multiple Sclerosis and Related Disorders, 55, 103219. https://doi.org/10.1016/j.msard.2021.103219
  8. Everitt B. S. (1975). Multivariate analysis: the need for data, and other problems. The British Journal of Psychiatry: The Journal of Mental Science, 126, 237–240. https://doi.org/10.1192/bjp.126.3.237
  9. Fortunato, R., van der Maas, N. A., Biland-Thommen, U., Kaufmann, M., Sieber, C., Kamm, C. P.,. & von Wyl, V. (2021). Physiotherapy use and access-barriers in persons with multiple sclerosis: A cross-sectional analysis. Multiple Sclerosis and Related Disorders, 48, 102710. https://doi.org/10.1016/j.msard.2020.102710
  10. Gözüm, S., & Aksayan, A. S. (2003). A guide for transcultural adaptation of the scale II: psychometric characteristics and cross-cultural comparison. Turkish Journal of Research and Development in Nursing, 5(1), 3-14.
  11. Kahraman, T., Özdoğar, A. T., & Özakbaş, S. (2021). Cross-cultural adaptation, validity and reliability of the Turkish version of the patient determined disease steps scale in persons with multiple sclerosis. Physiotherapy Theory and Practice, 37(4), 527–534. https://doi.org/10.1080/09593985.2019.1633715
  12. Kaufmann, M., Salmen, A., Barin, L., Puhan, M. A., Calabrese, P., Kamm, C. P., … & Swiss Multiple Sclerosis Registry (SMSR) (2020). Development and validation of the self-reported disability status scale (SRDSS) to estimate EDSS-categories. Multiple Sclerosis and Related Disorders, 42, 102148. https://doi.org/10.1016/j.msard.2020.102148
  13. Koo, T. K., & Li, M. Y. (2016). A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. Journal of Chiropractic Medicine, 15(2), 155–163. https://doi.org/10.1016/j.jcm.2016.02.012
  14. Kurtzke J. F. (1983). Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology, 33(11), 1444–1452. https://doi.org/10.1212/wnl.33.11.1444
  15. Prion, S., & Haerling, K. A. (2014). Making sense of methods and measurement: Pearson product-moment correlation coefficient. Clinical Simulation in Nursing. 11(10), 587-588. https://doi.org/10.1016/j.ecns.2014.07.010
  16. Puhan, M. A., Steinemann, N., Kamm, C. P., Müller, S., Kuhle, J., Kurmann, R., … & Swiss Multiple Sclerosis Registry Smsr (2018). A digitally facilitated citizen-science driven approach accelerates participant recruitment and increases study population diversity. Swiss Medical Weekly, 148, w14623. https://doi.org/10.4414/smw.2018.14623
  17. Reich, D. S., Lucchinetti, C. F., & Calabresi, P. A. (2018). Multiple Sclerosis. The New England Journal of Medicine, 378(2), 169–180. https://doi.org/10.1056/NEJMra1401483
  18. Rodgers, S., Manjaly, Z. M., Calabrese, P., Steinemann, N., Kaufmann, M., Salmen, A.,. & Ajdacic-Gross, V. (2021a). The Effect of Depression on Health-Related Quality of Life Is Mediated by Fatigue in Persons with Multiple Sclerosis. Brain Sciences, 11(6), 751. https://doi.org/10.3390/brainsci11060751
  19. Rodgers, S., Calabrese, P., Ajdacic-Gross, V., Steinemann, N., Kaufmann, M., Salmen, A.,. & von Wyl, V. (2021b). Major depressive disorder subtypes and depression symptoms in multiple sclerosis: What is different compared to the general population?. Journal of Psychosomatic Research, 144, 110402. https://doi.org/10.1016/j.jpsychores.2021.110402
  20. Schwartz, C. E., Vollmer, T., & Lee, H. (1999). Reliability and validity of two self-report measures of impairment and disability for MS. North American Research Consortium on Multiple Sclerosis Outcomes Study Group. Neurology, 52(1), 63–70. https://doi.org/10.1212/wnl.52.1.63
  21. Skjerbæk, A. G., Boesen, F., Petersen, T., Rasmussen, P. V., Stenager, E., Nørgaard, M., … & Dalgas, U. (2019). Can we trust self-reported walking distance when determining EDSS scores in patients with multiple sclerosis? The Danish MS hospitals rehabilitation study. Multiple Sclerosis (Houndmills, Basingstoke, England), 25(12), 1653–1660. https://doi.org/10.1177/1352458518795416
  22. Steinemann, N., Kuhle, J., Calabrese, P., Kesselring, J., Disanto, G., Merkler, D., … & Swiss Multiple Sclerosis Registry (2018). The Swiss Multiple Sclerosis Registry (SMSR): study protocol of a participatory, nationwide registry to promote epidemiological and patient-centered MS research. BMC Neurology, 18(1), 111. https://doi.org/10.1186/s12883-018-1118-0
  23. Vaz, S., Falkmer, T., Passmore, A. E., Parsons, R., & Andreou, P. (2013). The case for using the repeatability coefficient when calculating test-retest reliability. PloS One, 8(9), e73990. https://doi.org/10.1371/journal.pone.0073990
  24. Visser, L. A., Louapre, C., Uyl-de Groot, C. A., & Redekop, W. K. (2021). Health-related quality of life of multiple sclerosis patients: a European multi-country study. Archives of Public Health, 79(39), 1-12. https://doi.org/10.1186/s13690-021-00561-z
  25. Wallin, M. T., Culpepper, W. J., Nichols, E., Bhutta, Z. A., Gebrehiwot, T. T., Hay, S. I., Murray, C. J. L. (2019). Global, regional, and national burden of multiple sclerosis 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology, 18(3), 269-285. https://doi.org/10.1016/S1474-4422(18)30443-5
  26. Zurawski, J., Glanz, B. I., Chua, A., Lokhande, H., Rotstein, D., Weiner, H., … & Healy, B. C. (2019). Time between expanded disability status scale (EDSS) scores. Multiple Sclerosis and Related Disorders, 30, 98–103. https://doi.org/10.1016/j.msard.2019.02.007
  27. Fortunato, R., van der Maas, N. A., Biland-Thommen, U., Kaufmann, M., Sieber, C., Kamm, C. P.,. & von Wyl, V. (2021). Physiotherapy use and access-barriers in persons with multiple sclerosis: A cross-sectional analysis. Multiple Sclerosis and Related Disorders, 48, 102710. https://doi.org/10.1016/j.msard.2020.102710
  28. Rodgers, S., Manjaly, Z. M., Calabrese, P., Steinemann, N., Kaufmann, M., Salmen, A.,. & Ajdacic-Gross, V. (2021a). The Effect of Depression on Health-Related Quality of Life Is Mediated by Fatigue in Persons with Multiple Sclerosis. Brain Sciences, 11(6), 751. https://doi.org/10.3390/brainsci11060751
  29. Rodgers, S., Calabrese, P., Ajdacic-Gross, V., Steinemann, N., Kaufmann, M., Salmen, A.,. & von Wyl, V. (2021b). Major depressive disorder subtypes and depression symptoms in multiple sclerosis: What is different compared to the general population?. Journal of Psychosomatic Research, 144, 110402. https://doi.org/10.1016/j.jpsychores.2021.110402